|
|
Article: After the panic, clarifying the results of a cholesterol trial
- Article from:
- International Herald Tribune
- Article date:
- January 24, 2008
- Author:
-
|
Copyright informationProvided by ProQuest LLC. (Hide copyright information)
|
Tara Parker-Pope The New York Times Media Group
International Herald Tribune
01-24-2008
After the panic, clarifying the results of a cholesterol trial
Byline: Tara Parker-Pope The New York Times Media Group
Edition: 1
Section: FEATURES
The cholesterol drug Vytorin combines Zocor, a cholesterol- lowering statin, with Zetia, a drug that limits cholesterol's absorption into the body, and the hope was that the combination would make it more effective than either drug standing alone. But last week Vytorin's makers, Merck and Schering-Plough, announced that in a small study it had performed no better than Zocor alone in slowing the growth of arterial plaque, which can lead to heart attacks. There's ...
Related newspaper, magazine, and journal articles:
|
|
Article: Will an aspirin a day keep heart attacks away?
Chicago Sun-Times;
May 17, 1987 ;
700+ words
......of aspirin in preventing heart attacks and eight other studies that...Aspirin is not a drug without side effects. The most common are stomach...bleeding. However, these side effects usually appear in people...Medrol and I think it has many side effects. How soon do ...
|
|